PharmAI specializes in drug discovery through advanced chemoinformatics and structure analysis. Their offerings include focused library screening, scaffold diversification, and off-target identification, utilizing a knowledge-based approach and AI-driven technology to optimize compound libraries and enhance the precision of drug candidate identification. Their goal is to accelerate the drug discovery process while reducing costs and improving accuracy.